|
Anatara Update on GaRP Irritable Bowel Syndrome Trial
|
6 June 2023 at 8:40am
|
|
Anatara Investor Presentation
|
8 May 2023 at 11:10am
|
|
Registered Office Change
|
20 April 2023 at 12:20pm
|
|
Appendix 4C & Q3 FY23 Activities Report
|
20 April 2023 at 9:35am
|
|
Change in substantial holding
|
28 March 2023 at 10:55am
|
|
Anatara Company Update
|
10 March 2023 at 9:35am
|
|
Half Yearly Report and Accounts
|
24 February 2023 at 9:30am
|
|
Notification regarding unquoted securities - ANR
|
21 February 2023 at 7:15pm
|
|
Application for quotation of securities - ANR
|
21 February 2023 at 7:10pm
|
|
Placement of Shortfall from Entitlement Offer
|
21 February 2023 at 4:30pm
|
|
Application for quotation of securities - ANR
|
30 January 2023 at 8:40am
|
|
Notification of cessation of securities - ANR
|
19 January 2023 at 8:00pm
|
|
Revised Appendix 4C
|
13 January 2023 at 4:45pm
|
|
Appendix 4C & Q2 FY23 Activities Report
|
12 January 2023 at 8:45am
|
|
Change of Director's Interest Notice
|
20 December 2022 at 5:55pm
|
|
Notification regarding unquoted securities - ANR
|
20 December 2022 at 9:10am
|
|
Notification regarding unquoted securities - ANR
|
19 December 2022 at 2:35pm
|
|
Cleansing Notice
|
16 December 2022 at 4:55pm
|
|
Application for quotation of securities - ANR
|
16 December 2022 at 4:45pm
|
|
Change of Director's Interest Notice
|
14 December 2022 at 2:15pm
|
|
Notification of cessation of securities - ANR
|
12 December 2022 at 5:30pm
|
|
Notification of cessation of securities - ANR
|
12 December 2022 at 5:20pm
|
|
Results of Meeting
|
12 December 2022 at 2:15pm
|
|
Initial Director's Interest Notice
|
7 December 2022 at 9:35am
|
|
Final Director's Interest Notice
|
7 December 2022 at 9:35am
|
|
Board Changes
|
7 December 2022 at 9:30am
|
|
Change of Director's Interest Notice
|
30 November 2022 at 5:55pm
|
|
Notification regarding unquoted securities - ANR
|
28 November 2022 at 10:05am
|
|
Application for quotation of securities - ANR
|
28 November 2022 at 9:55am
|
|
Completion of Non-renounceable Entitlement Offer and Shortfa
|
25 November 2022 at 8:40am
|
|
Results of Meeting
|
11 November 2022 at 2:40pm
|
|
Chairman's Address to Shareholders
|
11 November 2022 at 12:50pm
|
|
AGM Clinical Trial Presentation
|
11 November 2022 at 12:45pm
|
|
Notice of General Meeting/Proxy Form
|
10 November 2022 at 5:05pm
|
|
Change in substantial holding - Tiga Trading Pty Ltd
|
31 October 2022 at 6:15pm
|
|
Change in substantial holding from TEK
|
31 October 2022 at 6:15pm
|
|
Entitlement Offer Letter to Shareholders
|
31 October 2022 at 1:05pm
|
|
Cleansing Notice
|
28 October 2022 at 10:30am
|
|
Application for quotation of securities - ANR
|
28 October 2022 at 10:20am
|
|
Appendix 4C & Q1 FY23 Activities Report
|
28 October 2022 at 8:35am
|
|
Proposed issue of securities - ANR
|
21 October 2022 at 9:25am
|
|
Proposed issue of securities - ANR
|
21 October 2022 at 9:25am
|
|
Proposed issue of securities - ANR
|
21 October 2022 at 9:25am
|
|
Entitlement Offer Prospectus
|
21 October 2022 at 9:25am
|
|
Placement and Entitlement Offer
|
21 October 2022 at 9:25am
|
|
Trading Halt
|
19 October 2022 at 9:20am
|
|
Annual Report to shareholders
|
14 October 2022 at 12:20pm
|
|
Appendix 4G and Corporate Governance Statement
|
14 October 2022 at 10:00am
|
|
Anatara Investor Presentation
|
13 October 2022 at 1:20pm
|
|
Notice of Annual General Meeting/Proxy Form
|
10 October 2022 at 6:45pm
|
Anatara Lifesciences